Health News

Factors Differ for Early vs Late TNFi Switch in AS Patients

Older age, higher subjective disease activity, and exercising for more than 120 minutes per week were three factors linked to patients with ankylosing spondylitis (AS) who switched from their original tumor necrosis factor inhibitor (TNFi) treatment within 2 years in a U.S.-based study. Data from the Prospective Study of Outcomes in Ankylosing Spondylitis (PSOAS) also […]

Health News

TNFi Have Delayed Effect on Spondyloarthritis Progression

Tumor necrosis factor inhibitors reduce both spinal and sacroiliac radiographic progression in early axial spondyloarthritis (axSpA), but the effects take time. According to data from the German Spondyloarthritis Inception Cohort (GESPIC), it could take 2-4 years after the initiation of TNF inhibitor treatment before x-rays will show any sign of a benefit in either the […]